|
|
![]() | ![]() | ![]() | ![]() |
| |||||||||
This excerpt taken from the ELN 20-F filed Feb 28, 2007. AAB-002
We anticipate a potential filing of an IND in 2007 for AAB-002,
a follow-on antibody program, which is also in collaboration
with Wyeth. This antibody has demonstrated unique attributes in
our experimental animal models when compared to AAB-001.
Table of Contents
This excerpt taken from the ELN 20-F filed Mar 30, 2006. AAB-002
We anticipate a potential filing of an IND in the latter half of
2006 for AAB-002, a follow-on antibody program, which is also in
collaboration with Wyeth. This antibody has demonstrated unique
attributes in our experimental animal models when compared to
AAB-001, and therefore represents a potential follow-on
candidate to the first-generation passive antibody.
Table of Contents
| EXCERPTS ON THIS PAGE:
|
| |||||||